Causes of Dysnatremia in Cancer Patients: A Review

Daniela Rădulescu *

Clinical Department no.3, University of Medicine and Pharmacy, Carol Davila, Bucharest, Eroii Sanitari 8, Bucharest, 050474, Romania and Nephrology and Dialysis Department, Clinical Emergency Hospital , Sf. Ioan, Bucharest, Vitan Barzesti 13, Bucharest, 042122, Romania.

Ileana Adela Văcăroiu

Clinical Department no.3, University of Medicine and Pharmacy, Carol Davila, Bucharest, Eroii Sanitari 8, Bucharest, 050474, Romania and Nephrology and Dialysis Department, Clinical Emergency Hospital , Sf. Ioan, Bucharest, Vitan Barzesti 13, Bucharest, 042122, Romania.

Flavia Liliana Turcu

Clinical Department no.3, University of Medicine and Pharmacy, Carol Davila, Bucharest, Eroii Sanitari 8, Bucharest, 050474, Romania and Nephrology and Dialysis Department, Clinical Emergency Hospital , Sf. Ioan, Bucharest, Vitan Barzesti 13, Bucharest, 042122, Romania.

Carmen Bogeanu

Clinical Department no.3, University of Medicine and Pharmacy, Carol Davila, Bucharest, Eroii Sanitari 8, Bucharest, 050474, Romania and Nephrology and Dialysis Department, Clinical Emergency Hospital , Sf. Ioan, Bucharest, Vitan Barzesti 13, Bucharest, 042122, Romania.

*Author to whom correspondence should be addressed.


Abstract

Dysnatremias occur with high incidence in cancer patients and have negative impact on quality of life, survival, hospitalization length. Both cancer and its therapy are responsible; coexisting comorbidities may also be involved. Hyponatremia is the most common electrolyte disorder and is usually multifactorial. Hypernatremia, although more rare, is associated with poorer outcome. Diagnosis of true dysnatremias may be a challenge in patients with active cancer, as they must be often differentiated from spurious dysnatremias. Assessing the extracellular volume is the first step for establishing the cause of a dysnatremia; as such hypovolemic, euvolemic and hypervolemic dysnatremias have distinct etiology. The present article briefly reviews cancer-specific and treatment-specific causes of dysnatremias.

Keywords: Cancer, cancer therapies, hyponatremia, hypernatremia, pseudodysnatremias, extracellular volume status, kidney dysfunction


How to Cite

Rădulescu, Daniela, Ileana Adela Văcăroiu, Flavia Liliana Turcu, and Carmen Bogeanu. 2022. “Causes of Dysnatremia in Cancer Patients: A Review”. Journal of Pharmaceutical Research International 34 (40A):6-13. https://doi.org/10.9734/jpri/2022/v34i40A36251.

Downloads

Download data is not yet available.